Peanut Patch Receives FDA’s Breakthrough Therapy Designation
The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.
FDA Provides Primer on Current State of Allergy Immunotherapies
We provide a summary for individuals new to the world of food allergies and therapies under investigation.
Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis
The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.
Auto-Injector? No… Epinephrine in a Tablet!
A researcher from Nova Southeastern University is working on a novel way to deliver epinephrine.
Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.
Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
Delivering the Next Generation Auto-Injector
CEO Christopher Stepanian tells us how Windgap's auto-injector seeks to 'improve the quality of life for patients living with severe allergies.'
Company Seeks to Remove the Allergist from Treating Food Allergy
AllergyEasy manufactures drops used in sublingual immunotherapy, not approved by the FDA for the treatment of food allergy.
Patent Issued for Innovative Auto-Injector Mechanism
Does this portend an auto-injector with a longer shelf-life, impervious to temperature changes, and the size of a USB thumb-drive that could be carried on a key chain?
Pharmaceutical Company Developing Inhalable Epinephrine
MannKind Corporation is developing a product that would dispose of the needle entirely.
